Castle Biosciences

CSTL

----

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Castle Biosciences(CSTL) predict that the Revenue is 83.68 M (-4.9%), Beat estimate;the EBIT is -18.41 M (+34.09%), Miss estimate;the EPS is -0.49 (+45.56%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.08B4.90%

0.08B9.95%

+0.00B5.05%

EBITMiss expectations

-0.02B34.09%

-0.02B41.29%

-0.00B7.20%

EPSMiss expectations

-0.4945.56%

-0.488845.69%

-0.00120.13%

Upcoming earnings report - FY2026 Q2 Earning Release

Available dateJul 30, 2026

Estimate Revenue86.24 M

Estimate EBIT-15 M

Estimate EPS-0.4066

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD